Monday, May 27, 2013
Europe's private and public biotechs in the clinic
both raised more money in 2012 vs. 2011. Of the $1.2 billion raised by private
biotechs in 2012, $806.3 million, or 66%, went to clinical-stage companies.
This compares to $442 billion, or 36% of the